Publicação
Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury
| dc.contributor.author | Patel, NSA | |
| dc.contributor.author | Cortes, U | |
| dc.contributor.author | Di Poala, R | |
| dc.contributor.author | Mazzon, E | |
| dc.contributor.author | Mota-Filipe, H | |
| dc.contributor.author | Cuzzocrea, S | |
| dc.contributor.author | Wang, ZQ | |
| dc.contributor.author | Thiemermann, C | |
| dc.date.accessioned | 2015-12-30T10:17:43Z | |
| dc.date.available | 2015-12-30T10:17:43Z | |
| dc.date.issued | 2005 | |
| dc.description.abstract | The role of poly(ADP-ribose) (PAR) glycohydrolase (PARG) in the pathophysiology of renal ischemia/reperfusion (I/R) injury is not known. Poly(ADP-ribosyl)ation is rapidly stimulated in cells after DNA damage caused by the generation of reactive oxygen and nitrogen species during I/R. Continuous or excessive activation of poly(ADP-ribose) polymerase-1 produces extended chains of ADP-ribose on nuclear proteins and results in a substantial depletion of intracellular NAD(+) and subsequently, ATP, leading to cellular dysfunction and, ultimately, cell death. The key enzyme involved in polymer turnover is PARG, which possesses mainly exoglycosidase activity but can remove olig(ADP-ribose) fragments via encloglycosidic cleavage. Thus, the aim of this study was to investigate whether the absence of PARG(110) reduced the renal dysfunction, injury, and inflammation caused by I/R of the mouse kidney. Here, the renal dysfunction and injury caused by I/R (bilateral renal artery occlusion [30 min] followed by reperfusion [24 h]) in mice lacking PARG(110), the major nuclear isoform of PARG, was investigated. The following markers of renal dysfunction and injury were measured: Plasma urea, creatinine, aspartate aminotransferase, and histology. The following markers of inflammation were also measured: Myeloperoxidase activity, malondialdehyde levels, and plasma nitrite/nitrate. The degree of renal injury and dysfunction caused by I/R was significantly reduced in PARG(110)-deficient mice when compared with their wild-type littermates, and there were no differences in any of the biochemical parameters measured between sham-operated PARG(110)(-/-) mice and sham-operated wild-type littermates. Thus, it is proposed that endogenous PARG(110) plays a pivotal role in the pathophysiology of I/R injury of the kidney. | |
| dc.format | application/pdf | |
| dc.identifier.citation | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. - Vol. 16, n. 3 (MAR 2005), p. 712-719 | |
| dc.identifier.doi | http://dx.doi.org/10.1681/ASN.2004080677 | |
| dc.identifier.issn | 1046-6673 | |
| dc.identifier.uri | http://hdl.handle.net/10451/21213 | |
| dc.language.iso | eng | |
| dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | |
| dc.subject | Urology & Nephrology | |
| dc.title | Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury | |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 719 | por |
| oaire.citation.startPage | 712 | por |
| oaire.citation.title | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | por |
| oaire.citation.volume | Vol. 16 | por |
| rcaap.rights | restrictedAccess | |
| rcaap.type | article |
